Former professor: ‘Postponement of vaccine campaigns probably due to AstraZeneca setback’ | NOW

The decrease in the first delivery of the AstraZeneca / Oxford vaccine to the European Union is a “major setback”, says Ben van der Zeijst, emeritus professor of vaccines and former head of Vaccines at the RIVM on Saturday morning in the NOS Radio 1 News. According to Van der Zeijst, reducing the number of vaccines supplied will probably lead to postponement for some groups that need to be vaccinated.

“However you arrange it, you have to put the vaccination puzzle again.

Incidentally, the emeritus professor sees opportunities to “still adapt a sleeve”, for example by postponing the second shot with the AstraZeneca vaccine, so that more people can get their first shot.

According to a health ministry delivery schedule from early this year, 4.5 million of the AstraZeneca vaccines would be delivered in the first quarter of this year. However, the first delivery of AstraZeneca is lower than expected, the pharmaceutical company said on Friday.

A senior EU official anonymously tells Reuters news agency that AstraZeneca will deliver 60 percent fewer vaccines than intended in the first quarter, at just 31 million doses.

Vaccine is used, among other things, for healthcare workers

The Ministry has ordered a total of 11.6 million vaccines from this supplier, a higher number than the other corona vaccines from Moderna and Pfizer / BioNTech. The vaccine will be used for the vaccination of healthcare workers and people up to the age of 60 with a medical indication and later on broader groups.

Next Friday, the European Medicines Agency EMA will issue an opinion on the use of the vaccine.


Leave a Reply

Your email address will not be published. Required fields are marked *